Global Imaging Agents Industry (2019 to 2027) - Market Trajectory & Analytics -

DUBLIN--()--The "Imaging Agents - Global Market Trajectory & Analytics" report has been added to's offering.

Amid the COVID-19 crisis and the looming economic recession, the Imaging Agents market worldwide will grow by a projected US$2.5 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 3.1%. Diagnostic Radiopharmaceuticals, one of the segments analyzed and sized in this study, is forecast to grow at over 3.5% and reach a market size of US$6.4 Billion by the end of the analysis period.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.

An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Diagnostic Radiopharmaceuticals market will be reset to a new normal which going forwards in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 1.9% CAGR. Within Europe, Germany will add over US$58.9 Million to the region's size over the next 7 to 8 years. In addition, over US$62.2 Million worth of projected demand in the region will come from Rest of European markets. In Japan, the Diagnostic Radiopharmaceuticals segment will reach a market size of US$311.7 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Imaging Agents market.

Against this backdrop and the changing geopolitical, business and consumer sentiments, the world's second largest economy will grow at 6.2% over the next couple of years and add approximately US$825.9 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Imaging Agents market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,

  • Aytu BioScience Inc.
  • Bayer Healthcare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Curium
  • Daiichi Sankyo Company Limited
  • Eli Lilly
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging Inc.
  • Piramal Imaging SA

Key Topics Covered:




  • Imaging Agents: Providing Brighter and Clearer Images for Effective Clinical Diagnosis
  • Recent Market Activity
  • Major Growth Drivers in a Nutshell
  • Growing Need for Early Disease Diagnosis Fosters Demand for Imaging Agents
  • Select Market Growth Restraints
  • Contrast Media: Giving Way to Contemporary Offshoots
  • X-ray/CT Segment Continues to Lead Contrast Media Market
  • Developed Economies Face Threat from Rising Demand for Contrast Agents in Asia-Pacific
  • Diagnostic Radiopharmaceuticals to Outdo Contrast Media
  • Nuclear Medicine: A Potential Growth Avenue for Dx Radiopharmaceuticals
  • Select PET and SPECT Radioisotopes Used in Nuclear Medicine
  • Select Cardiology and Oncology Radiopharmaceuticals
  • Developed Markets Rule the Imaging Agents Market, Developing Regions to Spearhead Future Growth
  • Global Competitor Market Shares
  • Imaging Agents Competitor Market Share Scenario Worldwide (in %): 2018 & 2029
  • Impact of Covid-19 and a Looming Global Recession



  • Sustained Expansion of Molecular Imaging Platform Presents Positive Outlook
  • Novel Radiopharmaceuticals Add New Dimensions to Molecular Imaging
  • Latest Radiopharmaceuticals to BenefitMolecular Imaging
  • Microbubbles/Ultrasound Contrast Agents Set for Strong Growth
  • Growing Interest in Image Guided Surgery Offers New Opportunities
  • Role of Near-Infrared Contrast Agents for Image Guided Surgery
  • Fluorescence Optical Imaging - Opens New Avenues
  • Coronary CT Angiography Opens Up Opportunities for Contrast Agents
  • List of Iodine-Containing Contrast Agents for Coronary CT Angiography
  • Targeted Imaging - A Game Changer in the Making
  • Rising Clinical Acceptance of MRI Systems Augurs Well for Contrast Agents Market
  • Researchers Develop Iron Oxide-based Contrast Agent for MRI
  • Nanomaterials Taking the Center Stage
  • New Nanoparticle Contrast Agents on the Horizon Show Promise
  • Gadolinium Coated Nanoparticles - A Promising Imaging Agent
  • Growing Focus on Development of Gold Nanoparticles in X-Ray Imaging
  • Imaging Agents Make a Welcome Impact in the Field of Alzheimer's Disease
  • List of FDA Approved Alzheimer's Diagnostic Imaging Agents
  • Contrast-Enhanced Tomosynthesis Expands Opportunities
  • Hyperpolarized Gases as Contrast Agents
  • Multi-Modal Imaging: Combating Contrast Medium Inconsistencies
  • Falling Prices Turn on the Heat
  • Ultrasound Contrast Agents in Diagnosis of Kidney Ailments
  • PET: A Prime Growth Driver for Diagnostic Radiopharmaceuticals
  • Innovative Radiotracers to Boost Cardiac Applications for SPECT and PET Modalities
  • A Peek at Global CVD Stats
  • Echocardiography Examinations -Improving Diagnostic Quality through Contrast Agents
  • Opportunities on Rise for Fluorine-Based Myocardial Perfusion Agents
  • Unfounded Fears of Radiation Exposure: A Major Concern for Nuclear Diagnostics
  • Rising Incidence of Cancer - A Major Growth Driver
  • World Cancer Statistics - Incidence and Mortality Data
  • Improving Healthcare Expenditure to Foster Growth
  • Aging Population - A Vital Demography
  • A Peek into Pricing Dynamics
  • Packaging of Contrast Agents - An Overview
  • Global Supply Shortages Restrains Radiopharmaceuticals Market
  • Price Sensitivity & Competition from Alternatives
  • Lack of Dosage Standards for Pediatric Patients LimitsRadiopharmaceutical Efficacy
  • Reimbursement Scenario




Total Companies Profiled: 52

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900